FOCUS on Drug Repurposing. Moxidectin is an anthelmintic drug approved by the FDA in 2018 for onchocerciasis (river-blindness). It is a derivative of milbemycin, a structurally […]
The Focus Biomolecules Website is set to allow the use of cookies. Cookies help us to give you the best experience on our website. By clicking Accept or continuing to use the site, you agree to use our cookies. If you decline we will not track your information but your browsing experience might be limited. For more information on our Privacy Policy click here.
